Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Go back to Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 154.47 -3.6 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.07 | 52 Week High | $0.52 | |||
| Open | $158.36 | 52 Week Low | $0.08 | |||
| Day High | $159.79 | P/E | N/A | |||
| Day Low | $153.80 | EPS | $-3.80 | |||
| Volume | 2,792,822 | |||||
